All stock lists
MiNK Therapeutics, Inc. (NASDAQ:INKT)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
10.51-0.20 (-1.87%)
Insider Score
––Not scored
INKT Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
INKT Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Growth (YoY) | — | — | — | — | — | — |
| Cost of Revenue | 36.06 K | 36.07 K | 38.56 K | 43.65 K | 48.76 K | 50.77 K |
| Gross Profit | -36.06 K | -36.07 K | -38.56 K | -43.65 K | -48.76 K | -50.77 K |
| SG&A Expense | 1.33 M | 1.64 M | 1.72 M | 1.80 M | 1.85 M | 1.22 M |
| R&D Expense | 1.89 M | 1.20 M | 1.51 M | 1.14 M | 1.84 M | 1.26 M |
| Operating Expenses | 3.18 M | 2.85 M | 3.24 M | 2.95 M | 3.64 M | 2.48 M |
| Operating Income | -3.22 M | -2.88 M | -3.28 M | -2.99 M | -3.69 M | -2.53 M |
| Pretax Income | -3.13 M | -2.74 M | -2.60 M | -2.89 M | -4.24 M | -2.77 M |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -3.13 M | -2.74 M | -2.60 M | -2.89 M | -4.24 M | -2.77 M |
| EPS (Basic) | -0.62 | -0.57 | -0.55 | -0.65 | -1.06 | -0.70 |
| EPS (Diluted) | -0.62 | -0.57 | -0.55 | -0.65 | -1.06 | -0.70 |
| Shares Outstanding | 5.02 M | 4.80 M | 4.27 M | 4.44 M | 3.98 M | 3.96 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.